Otosclerosis F016
Current RMA Instruments:
| Reasonable Hypothesis SOP | 61 of 2016 |
| Balance of Probabilities SOP | 62 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 387
- ICD-10-AM Codes: H80
Brief description
Otosclerosis is a metabolic bone disease in which scarred bone is formed in the middle ear, resulting in conductive hearing loss.
Confirming the diagnosis
Diagnosis is based on characteristic clinical findings, which include progressive conductive hearing loss, a normal tympanic membrane, and no evidence of middle ear inflammation.
The relevant medical specialist is an ENT surgeon.
Additional diagnoses covered by SOP
- Cochlear otosclerosis
- Otospongiosis
Clinical onset
Clinical onset will usually be when hearing loss, subsequently confirmed to be due to otosclerosis, is first recorded. Onset is typically between ages 10 and 30.
Clinical worsening
The only SOP worsening factor is for inablitiy to obtain appropriate clinical management. Treament may involve observation, dietary supplements (sodium fluoride), surgery or hearing aids. Progression of the disease and the conductive hearing loss may be slowed by diet therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/n-p/otosclerosis-f016-h80
Rulebase for otosclerosis
<h5>Current RMA Instruments:</h5><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2016/061.pdf" target="_blank">Reasonable Hypothesis SOP</a></address></td><td>61 of 2016</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2016/062.pdf" target="_blank">Balance of Probabilities SOP </a></address></td><td>62 of 2016</td></tr></tbody></table><h5>Changes from previous Instruments:</h5><p><drupal-media data-entity-type="media" data-entity-uuid="f2db1da3-50d6-4ba8-bc3d-a0002c61005f" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding:</h5><ul><li>ICD-9-CM Codes: 387</li><li>ICD-10-AM Codes: H80</li></ul><h5>Brief description</h5><p>Otosclerosis is a metabolic bone disease in which scarred bone is formed in the middle ear, resulting in conductive hearing loss.</p><h5><b>Confirming the diagnosis</b></h5><p>Diagnosis is based on characteristic clinical findings, which include progressive conductive hearing loss, a normal tympanic membrane, and no evidence of middle ear inflammation.</p><p>The relevant medical specialist is an ENT surgeon.</p><h5><b>Additional diagnoses covered by SOP </b></h5><ul><li>Cochlear otosclerosis</li><li>Otospongiosis</li></ul><h5><b>Clinical onset</b></h5><p>Clinical onset will usually be when hearing loss, subsequently confirmed to be due to otosclerosis, is first recorded. Onset is typically between ages 10 and 30.</p><p><b>Clinical worsening</b></p><p>The only SOP worsening factor is for inablitiy to obtain appropriate clinical management. Treament may involve observation, dietary supplements (sodium fluoride), surgery or hearing aids. Progression of the disease and the conductive hearing loss may be slowed by diet therapy.</p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/rulebase-otosclerosis
Inability to obtain appropriate clinical management for otosclerosis
Current RMA Instruments:
| Reasonable Hypothesis SOP | 61 of 2016 |
| Balance of Probabilities SOP | 62 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 387
- ICD-10-AM Codes: H80
Brief description
Otosclerosis is a metabolic bone disease in which scarred bone is formed in the middle ear, resulting in conductive hearing loss.
Confirming the diagnosis
Diagnosis is based on characteristic clinical findings, which include progressive conductive hearing loss, a normal tympanic membrane, and no evidence of middle ear inflammation.
The relevant medical specialist is an ENT surgeon.
Additional diagnoses covered by SOP
- Cochlear otosclerosis
- Otospongiosis
Clinical onset
Clinical onset will usually be when hearing loss, subsequently confirmed to be due to otosclerosis, is first recorded. Onset is typically between ages 10 and 30.
Clinical worsening
The only SOP worsening factor is for inablitiy to obtain appropriate clinical management. Treament may involve observation, dietary supplements (sodium fluoride), surgery or hearing aids. Progression of the disease and the conductive hearing loss may be slowed by diet therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/otosclerosis-f016-h80/rulebase-otosclerosis/inability-obtain-appropriate-clinical-management-otosclerosis
Infection with measles virus
Current RMA Instruments:
| Reasonable Hypothesis SOP | 61 of 2016 |
| Balance of Probabilities SOP | 62 of 2016 |
Changes from previous Instruments:
ICD Coding:
- ICD-9-CM Codes: 387
- ICD-10-AM Codes: H80
Brief description
Otosclerosis is a metabolic bone disease in which scarred bone is formed in the middle ear, resulting in conductive hearing loss.
Confirming the diagnosis
Diagnosis is based on characteristic clinical findings, which include progressive conductive hearing loss, a normal tympanic membrane, and no evidence of middle ear inflammation.
The relevant medical specialist is an ENT surgeon.
Additional diagnoses covered by SOP
- Cochlear otosclerosis
- Otospongiosis
Clinical onset
Clinical onset will usually be when hearing loss, subsequently confirmed to be due to otosclerosis, is first recorded. Onset is typically between ages 10 and 30.
Clinical worsening
The only SOP worsening factor is for inablitiy to obtain appropriate clinical management. Treament may involve observation, dietary supplements (sodium fluoride), surgery or hearing aids. Progression of the disease and the conductive hearing loss may be slowed by diet therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/otosclerosis-f016-h80/rulebase-otosclerosis/infection-measles-virus